Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$383M |
| 2 |
Costco
COST
|
+$267M |
| 3 |
Pfizer
PFE
|
+$231M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$227M |
Top Sells
| 1 |
CVS Health
CVS
|
+$258M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
+$216M |
| 4 |
Charter Communications
CHTR
|
+$142M |
| 5 |
TE
TECO ENERGY INC
TE
|
+$136M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.63% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AINC
2901
DELISTED
Ashford Inc.
AINC
| $366K | ﹤0.01% |
7,680
+200
| +3% | +$9.53K |
|
|
BOCH
2902
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $364K | ﹤0.01% |
50,600
+9,300
| +23% | +$66.9K |
|
2903
America's Car Mart
CRMT
$293M
| $363K | ﹤0.01% |
+9,972
| New | +$363K |
|
2904
Paramount Gold Nevada
PZG
$73.6M
| $360K | ﹤0.01% |
178,900
+149,200
| +502% | +$300K |
|
|
CYAN
2905
DELISTED
Cyanotech Corp
CYAN
| $360K | ﹤0.01% |
97,600
+1,300
| +1% | +$4.8K |
|
|
IOC
2906
DELISTED
Interoil Corporation
IOC
| $360K | ﹤0.01% |
7,072
-52,000
| -88% | -$2.65M |
|
2907
InfuSystem Holdings
INFU
$207M
| $359K | ﹤0.01% |
129,000
-31,000
| -19% | -$86.3K |
|
|
JAX
2908
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $359K | ﹤0.01% |
35,400
+3,400
| +11% | +$34.5K |
|
|
SANW
2909
DELISTED
S&W Seed Co
SANW
| $358K | ﹤0.01% |
3,689
+312
| +9% | +$30.3K |
|
|
SKIS
2910
DELISTED
Peak Resorts, Inc.
SKIS
| $358K | ﹤0.01% |
+69,600
| New | +$358K |
|
2911
Bel Fuse Class A
BELFA
$1.58B
| $357K | ﹤0.01% |
17,700
+400
| +2% | +$8.07K |
|
2912
Omega Flex
OFLX
$347M
| $355K | ﹤0.01% |
+9,200
| New | +$355K |
|
2913
Colony Bankcorp
CBAN
$305M
| $353K | ﹤0.01% |
35,700
+2,300
| +7% | +$22.7K |
|
2914
vTv Therapeutics
VTVT
$52.5M
| $352K | ﹤0.01% |
+1,225
| New | +$352K |
|
|
TISA
2915
DELISTED
TOP Image Systems Ltd
TISA
| $352K | ﹤0.01% |
158,526
-6,122
| -4% | -$13.6K |
|
2916
RLI Corp
RLI
$6.15B
| $349K | ﹤0.01% |
+10,200
| New | +$349K |
|
2917
Westlake Chemical Partners
WLKP
$770M
| $349K | ﹤0.01% |
15,300
-5,000
| -25% | -$114K |
|
|
AIFU
2918
AIFU Inc. Class A Ordinary Share
AIFU
$85.8M
| $347K | ﹤0.01% |
2,250
-170
| -7% | -$26.2K |
|
2919
ReposiTrak
TRAK
$314M
| $345K | ﹤0.01% |
+29,200
| New | +$345K |
|
|
B
2920
DELISTED
Barnes Group Inc.
B
| $345K | ﹤0.01% |
8,500
-119,100
| -93% | -$4.83M |
|
|
OSB
2921
DELISTED
Norbord Inc.
OSB
| $345K | ﹤0.01% |
13,400
-23,900
| -64% | -$615K |
|
|
FINL
2922
DELISTED
Finish Line
FINL
| $344K | ﹤0.01% |
+14,887
| New | +$344K |
|
|
MMAC
2923
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $340K | ﹤0.01% |
+18,667
| New | +$340K |
|
|
MDR
2924
DELISTED
McDermott International
MDR
| $339K | ﹤0.01% |
22,533
+3,566
| +19% | +$53.6K |
|
2925
Phio Pharmaceuticals
PHIO
$13.3M
| $336K | ﹤0.01% |
3
+1
| +50% | +$112K |
|